Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Healthdyne

This article was originally published in The Gray Sheet

Executive Summary

Healthdyne: European launch of disposable, single-use probe for non-invasive fetal oximetry is slated for late 1997, President and CEO Craig Reynolds says June 18 at the Dillon, Read & Company medical technology conference in New York City. A U.S. launch will follow FDA clearance of a premarket approval application. The device gives a "direct measurement of oxygen, it gives...a quantitative number," the exec said. Reynolds originally predicted a 1997 U.S. launch for the system at a December 1995 investor's conference ("The Gray Sheet I&W-11)...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT008322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel